百克生物
(688276)
| 流通市值：66.19亿 | | | 总市值：66.19亿 |
| 流通股本：4.14亿 | | | 总股本：4.14亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 304,515,641.22 | 147,351,373.49 | 605,072,927.68 | 474,442,765.98 |
| 营业总成本 | 349,141,327.21 | 150,517,283.29 | 846,820,195.84 | 628,977,112.72 |
| 其他经营收益 | | | | |
| 营业利润 | -64,550,524.43 | -7,674,272.41 | -332,325,649.25 | -226,720,962.84 |
| 利润总额 | -64,552,135.26 | -7,543,845.22 | -331,903,612.67 | -204,575,646.81 |
| 净利润 | -52,100,116.48 | -3,474,143.66 | -262,580,724.19 | -158,250,519.93 |
| 每股收益 | | | | |
| 其他综合收益 | -3,856,115.49 | -2,189,991.99 | -11,697,785.17 | -9,002,103.61 |
| 综合收益总额 | -55,956,231.97 | -5,664,135.65 | -274,278,509.36 | -167,252,623.54 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,538,193,486.61 | 1,480,079,097.45 | 1,422,924,819.47 | 1,635,849,991.63 |
| 非流动资产: | | | | |
| 非流动资产合计 | 3,592,813,601.52 | 3,647,805,025.57 | 3,645,496,458.63 | 3,574,346,652.42 |
| 资产总计 | 5,131,007,088.13 | 5,127,884,123.02 | 5,068,421,278.1 | 5,210,196,644.05 |
| 流动负债: | | | | |
| 流动负债合计 | 1,233,882,906.7 | 1,154,932,568.13 | 1,104,841,413.73 | 1,172,887,445.14 |
| 非流动负债: | | | | |
| 非流动负债合计 | 102,753,920.8 | 127,583,639.27 | 112,631,984.9 | 79,709,966.36 |
| 负债合计 | 1,336,636,827.5 | 1,282,516,207.4 | 1,217,473,398.63 | 1,252,597,411.5 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 3,794,370,260.63 | 3,845,367,915.62 | 3,850,947,879.47 | 3,957,599,232.55 |
| 股东权益合计 | 3,794,370,260.63 | 3,845,367,915.62 | 3,850,947,879.47 | 3,957,599,232.55 |
| 负债和股东权益合计 | 5,131,007,088.13 | 5,127,884,123.02 | 5,068,421,278.1 | 5,210,196,644.05 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 463,525,016.85 | 196,553,655.09 | 1,206,355,425.95 | 796,730,217.89 |
| 经营活动现金流出小计 | 415,166,998.93 | 177,868,066.7 | 975,148,367.78 | 811,539,568.49 |
| 经营活动产生的现金流量净额 | 48,358,017.92 | 18,685,588.39 | 231,207,058.17 | -14,809,350.6 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 19,300 | 19,300 | 64,400.01 | - |
| 投资活动现金流出小计 | 168,276,150.51 | 76,046,956.07 | 456,486,505.07 | 286,791,093.25 |
| 投资活动产生的现金流量净额 | -168,256,850.51 | -76,027,656.07 | -456,422,105.06 | -286,791,093.25 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 348,386,554.49 | 126,165,360.47 | 334,651,920.07 | 269,084,835.71 |
| 筹资活动现金流出小计 | 144,780,401.49 | 54,522,529.19 | 247,274,830.95 | 149,172,656.33 |
| 筹资活动产生的现金流量净额 | 203,606,153 | 71,642,831.28 | 87,377,089.12 | 119,912,179.38 |
| 汇率变动对现金及现金等价物的影响 | -342,390.11 | -72,815.24 | -158,504.54 | -105,967.58 |
| 现金及现金等价物净增加额 | 83,364,930.3 | 14,227,948.36 | -137,996,462.31 | -181,794,232.05 |
| 期末现金及现金等价物余额 | 284,602,488.33 | 215,465,506.39 | 201,237,558.03 | 157,439,788.29 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 83,364,930.3 | - | -137,996,462.31 | - |